Lost in Translation - Moving Your Research to Clinical Trials
In this webinar hosted by FierceBiotech and sponsored by STEMCELL Technologies, Dr. Adrian Gee from the Baylor College of Medicine and Dr. David McKenna from the University of Minnesota discuss the process of translating cell therapy research to the clinic. Learn how you can ease the transition of your preclinical research by considering regulatory requirements in the early stages, and how optimization, engineering processes, and other factors affect timelines and clinical trials.
Publish Date:
May 14, 2021
Related Multimedia
-
Qualification of Ancillary/Raw Materials for Clinical Use
Publish Date: June 20, 2018 -
The Impact of Ancillary Materials on Your Translational Research
Publish Date: September 11, 2019 -
Determining the Potency & Stability of Hematopoietic Cells
Publish Date: April 29, 2020
Explore Our Products
-
Automated closed-system immunomagnetic cell isolation instrument -
cGMP medium, for culture and expansion of human hematopoietic cells -
cGMP, animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells -
Serum-free methylcellulose-based medium with recombinant cytokines for human ES and iPS cell-derived cells
